Skip to main content
. 2023 Jan 10;15(2):338. doi: 10.3390/nu15020338

Table 2.

Demographics and clinical characteristics of SBS patients.

Class Variable Temporary SBS (n = 26) SBS-JC
(n = 21)
SBS-JIC
(n = 12)
SBS-I
(n = 6)
SBS + TED
(n = 5)
p-Value
Demo-graphics Age (years) 58 (49; 69) 64 (45; 74) 57 (43; 69) 50 (32; 63) 56 (47;64) 0.57
Gender (female) 13 (50) 17 (81) 8 (61.5) 1 (16.7) 1 (20) 0.02
Etiology (%) Ischemia (A/V) 11/6 (65.4) 10/0 (47.6) 3/4 (53.8) 1 (16.7) 1/1 (40) 0.25
IBD (CD/UC) 6/1 (26.9) 4/0 (19) 1 (7.7) 5 (83.3) 0 (0) <0.01
Radiation 1 (3.8) 3 (14.3) 2 (15.4) 0 (0) 0 (0) 0.48
Surgical/adhesion 1 (3.8) 3 (14.3) 2 (15.4) 0 (0) 3 (60) 0.01
Trauma/volvulus 0 (0) 1 (4.8) 1 (7) 0 (0) 0 (0) 0.65
IF class (%) FE 2 (7.7) 0 (0) 0 (0) 3 (50) 0 (0) <0.001
PN1 (≤1 L) 2 (7.7) 2 (9.5) 0 (0) 0 (0) 0 (0) 0.69
PN2 (1–2 L) 10 (38.5) 8 (38.1) 4 (30.8) 3 (50) 0 (0) 0.46
PN3 (2–3 L) 8 (30.8) 4 (19) 2 (15.4) 0 (0) 1 (20) 0.50
PN4 (>3 L) 4 (15.4) 7 (33.3) 7 (53.8) 0 (0) 4 (80) <0.01
Total SB (cm) 300 (240; 330) 105 (70; 160) 160 (70; 190) 250 (200; 300) 75 (69; 80) <0.0001
Anatomy Ileum (cm) 120 (13; 235) 0 (0; 0) 50 (25; 120) NA 0 (0; 10) <0.0001
Colon (%) 100 (86; 100) 75 (70; 90) 100 (100; 100) NA 80 (63; 88) <0.0001
Duration IVS (weeks) 10.5 (7; 14) 40 (28.5; 67) 23 (14.5; 64) 62.5 (35; 141) 166 (93.5; 376) <0.0001
FU (weeks) 29 (15; 48) 39 (12.5:84.5) 22 (15; 83.5) 40.5 (9; 45) 137 (76; 156) 0.04

Continuous data were reported as median (IQR) and categorical data as proportions (%) and analyzed using Kruskal–Wallis and chi-square tests, respectively. Abbreviations: arterial (A), Crohn’s disease (CD), fluids and electrolytes (FE), follow-up (FU), inflammatory bowel diseases (IBD), intestinal failure (IF), intravenous support (IVS), parenteral nutrition (PN), small bowel (SB), short bowel syndrome (SBS), ileostomy (SBS-I), jejuno-colic anastomosis (SBS-JC), jejuno-ileal anastomosis (SBS-JIC), teduglutide (TED), ulcerative colitis (UC), and venous (V).